PAULA WALKER: Open Payments
NPI 1023323938 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 96 payments from 17 companies in 2025. Trend: 2023 $2,355 · 2024 $2,576 · 2025 $1,831
Food & beverage: $1,741Education: $90
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $390 |
| Janssen Biotech, Inc. | 13 | $237 |
| Regeneron Healthcare Solutions, Inc. | 8 | $215 |
| ABBVIE INC. | 18 | $204 |
| Novartis Pharmaceuticals Corporation | 7 | $160 |
| Organon LLC | 12 | $101 |
| LEO Pharma Inc. | 4 | $95 |
| UCB, Inc. | 3 | $89 |
| Lilly USA, LLC | 4 | $82 |
| Botanix SB Inc | 3 | $49 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, Bimzelx, TALTZ, ADBRY, SOFDRA.
Industry payments across FL — which companies pay providers there.
